Foresite Capital Raises $173 Million To Fund Foresite Labs Incubated Life Science Companies
Mar 03, 2022•over 3 years ago
Amount Raised
$173 Million
Description
Foresite Capital, a multi-stage healthcare and life sciences investment firm, today announced it has raised a $173 million fund to further invest in companies launched by Foresite Labs. Foresite Labs companies will also continue to be supported from Foresite Capital Fund V and its associated opportunities fund. The fund comes on the heels of several major milestones for Foresite Capital including the announcement of its $969 million Fund V and investments in Foresite Labs incubated companies Interline Therapeutics, Alumis and TenSixteen Bio.
FundzWatch™ Score
74
Medium Activity
Buyer Intent Analysis
Get personalized insights on buying likelihood
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech